T-5224 possesses the capacity to eradicate Bmi1+ CSCs, hence inhibiting the development of HNSCC tumors and overcoming chemoresistance caused by CSCs in a spontaneous mouse model of HNSCC [96]. Here, BMI1 is linked to head and neck squamous cell carcinoma.